Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Please consider supporting us by disabling or pausing your ad blocker.
Chandra Kanthen Jumbulingam
-
//=$comment_count ?>
-
Following
0
-
Followers
0
Fame: 18
Joined Jan 2021
Comments
Chandra Kanthen Jumbulingam replied to comment on KANGER-OR.
4 years
·
translate
Hartalega is one of compay with highest DY.Keep buying when the price is low.TP is 8.50 by end of the year .If you don't hv patient, don't invest.
my self at 12th floor....I don't bother much...bcoz its long term investment and I keep averaging monthly.
Only those with long term investment will survive in stock market.Those hv cut loss might regard today.Just keep buying and averaging your stocks while enjoy the dividend given.
yes...news published in EDGE today projected positive outlook on Kanger.Their plan for long term will boost the earning per share in last quarter this year.As I mention before our target is 0.20...resistance at 0.13 and 0.16
see told rdy last week..wait until 0.12...go Kanger.
Malaysia hv approved Sinopharm vaccine today.Great news for KANGER and might hit 0.15 soon.
i am at 12th floor....only able to see Just will be long term trader.
yes ...
cases rising back world wide.Delta Variant causing new spike across the world.
cases rising back world wide.Delta Variant causing new spike across the world.
Cases rising and New lockdowns at few countries due to Delta variant.We might see some demand in healthcare sector this week.
Load more